Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database

Kaito Yamashiro1,2, Mika Jouta2, Kouichi Hosomi3

  • 1Laboratory of Public Health, Faculty of Pharmacy, Kindai University, 3-4-1, Kowakae, Higashi-Osaka, Osaka, 577-8502, Japan.

Scientific Reports
|October 21, 2022
PubMed

Insights

Microscopic colitis (MC) is a chronic condition causing watery diarrhea. This study suggests lansoprazole, aspirin, and nicorandil may be associated with MC development, particularly in older women and those with obesity.

Area of Science:

  • Gastroenterology
  • Pharmacovigilance
  • Epidemiology

Background:

  • Microscopic colitis (MC) is a chronic inflammatory bowel disease presenting with watery diarrhea.
  • Epidemiological data on MC in Japan is limited compared to Western countries.
  • Understanding factors associated with MC is crucial for diagnosis and management.

Purpose of the Study:

  • To investigate potential associations between drug use and microscopic colitis in Japan.
  • To generate hypotheses regarding factors contributing to MC development using real-world data.

Main Methods:

  • Analysis of the Japanese Adverse Drug Event Report (JADER) database from 2004 to 2021.
  • Inclusion of 161 cases of microscopic colitis (MC) out of 246,997 total reports.
  • Application of Weibull analysis for onset duration and logistic regression for association analysis.

Main Results:

  • MC was significantly associated with female sex, age ≥ 60 years, and use of lansoprazole, aspirin, and nicorandil.
  • Median onset duration for MC was 72.5 days for lansoprazole and 116.0 days for aspirin users.
  • Obesity showed a positive association with MC in female cases.

Conclusions:

  • The study suggests potential associations between microscopic colitis and the drugs lansoprazole, aspirin, and nicorandil.
  • Findings highlight specific demographic factors (female sex, age ≥ 60) and obesity as potentially relevant.
  • While causality cannot be inferred, these associations warrant further investigation.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
961
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
304
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
223
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
192
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
294
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
268